Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 RegistryArticle Published on 2021-04-232022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Admission Admissions age all-cause mortality Analysis antirheumatic agents Autoimmune disease Autoimmune diseases Barthel Index Biological biological therapy Clinical characteristics Clinical course Comorbidity complications Corticosteroid COVID-19 death decrease diagnosed with COVID-19 disease disease-modifying anti-rheumatic drug Effects Factor female General population Glucocorticoids greater Habitual hospitalized patient ICU immune system diseases in-hospital complications increased risk information intensive care invasive involved mechanical ventilation Mortality multivariate logistic regression Non-invasive Older outcome outcomes Patient patients patients with COVID-19 Poor Primary outcome Prognosis readmission registry SARS-CoV-2 secondary outcome selected Spanish subsequent Treatment variables Weighting with COVID-19 [DOI] 10.3390/jcm10091844 PMC 바로가기 [Article Type] Article
COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusionsCOVID-19 유발 과염증, 면역억제, 회복 및 생존: 인과관계 추론이 강력한 결론을 도출하는 데 어떻게 도움이 되는지Article Published on 2021-03-012022-09-12 Journal: RMD Open [Category] SARS, 진단, [키워드] addition Analysis antirheumatic agents C reactive protein Causal Clinical improvement COVID-19 criterion CRP defined Effect Effects Epidemiology experiments Glucocorticoids glucocorticoids. help hyperinflammation Immunosuppressant Immunosuppression Immunosuppressive treatment Inclusion indirect effects Intensive life-threatening Mediation analysis Methylprednisolone Mortality outcome Patient patients with COVID-19 prognostic provide randomised controlled trial robust supportive care Supportive treatment survival syndrome systemic hyperinflammation Tocilizumab treat Treatment Trial was performed was recorded [DOI] 10.1136/rmdopen-2021-001638 PMC 바로가기 [Article Type] Article
Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: ‘Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)’ by Giollo et alComment Published on 2021-02-012023-07-14 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] Anti-Inflammatory Agents, Non-Steroidal antirheumatic agents Inflammation. [DOI] 10.1136/annrheumdis-2020-217638 PMC 바로가기 [Article Type] Comment
Antirheumatic agents in covid-19: is IL-6 the right target?Comment Published on 2021-01-012023-07-14 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] antirheumatic agents cardiovascular diseases Inflammation patient care team. [DOI] 10.1136/annrheumdis-2020-217523 PMC 바로가기 [Article Type] Comment
Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemicReview Published on 2021-01-012023-07-05 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] antirheumatic agents biological therapy communicable diseases Hydroxychloroquine imported. [DOI] 10.1136/annrheumdis-2020-219217 PMC 바로가기 [Article Type] Review
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from IndiaComment Published on 2021-01-012023-07-14 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] antirheumatic agents Autoimmune diseases biological therapy communicable diseases, imported glucocorticoids. [DOI] 10.1136/annrheumdis-2020-217509 PMC 바로가기 [Article Type] Comment
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseasesObservational Study Published on 2020-11-012023-07-12 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] antirheumatic agents communicable diseases Epidemiology Health care imported outcome assessment. [DOI] 10.1136/annrheumdis-2020-217984 PMC 바로가기 [Article Type] Observational Study
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case seriesArticle Published on 2020-10-012023-07-11 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] antirheumatic agents biological therapy Cytokines interleukin 1 receptor antagonist protein Therapeutics. [DOI] 10.1136/annrheumdis-2020-217706 PMC 바로가기
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndromeArticle Published on 2020-10-012023-07-11 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] Anti-Inflammatory Agents, Non-Steroidal antirheumatic agents communicable diseases, imported Inflammation Therapeutics. [DOI] 10.1136/annrheumdis-2020-217712 PMC 바로가기
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanerceptCase Reports Published on 2020-09-012023-06-19 Journal: Annals of the rheumatic diseases [Category] Fulltext, SARS, [키워드] antirheumatic agents arthritis, infectious biological therapy spondylitis, ankylosing tumour necrosis factor inhibitors. [DOI] 10.1136/annrheumdis-2020-217362 PMC 바로가기 [Article Type] Case Reports